首页 > 最新文献

Innovation and entrepreneurship in health最新文献

英文 中文
Developing a technology-based intervention for empowering cancer patients from low-income backgrounds: a lifecycle approach 为低收入背景的癌症患者开发基于技术的干预措施:生命周期方法
Pub Date : 2019-05-15 DOI: 10.2147/IEH.S133549
A. Varanasi, K. Helzlsouer
Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: https://youtu.be/Z2KpVhZQloE Abstract: Despite significant advances across the cancer continuum from prevention through survivorship, achieving uniform high-quality, patient-centered care for all remains a challenge. We have entered the era of precision medicine and multi-modal treatment where the promise of cure is great. Yet fragmented care and disparities in cancer outcomes persist, especially among those individuals from low income and underresourced backgrounds. Thoughtful, mindful, and purposeful implementation of technology-based innovations have the potential to empower cancer patients and improve longterm outcomes and overall quality of life. These innovations have the potential to provide access to early detection and treatment and to extend and streamline cancer care coordination efforts by complementing and enhancing provider roles throughout the cancer continuum. Technology can be leveraged to mitigate limited resources and in turn improve long-term cancer outcomes for low-income cancer patients. While innovations in technology span a broad spectrum of advancement, we focus here on a technologybased intervention that serves the end goal of empowering patients throughout the cancer continuum as an example of what can be done to support cancer care and management through technology-based innovations.
将您的智能手机指向上面的代码。如果你有一个二维码阅读器,视频摘要就会出现。或者使用:https://youtu.be/Z2KpVhZQloE摘要:尽管癌症从预防到存活取得了重大进展,但实现以患者为中心的统一高质量护理仍然是一项挑战。我们已经进入了精准医疗和多模式治疗的时代,在这个时代,治愈的希望是巨大的。然而,分散的护理和癌症结果的差异仍然存在,尤其是在那些低收入和资源不足背景的人中。深思熟虑、专注和有目的地实施基于技术的创新有可能增强癌症患者的能力,改善长期结果和整体生活质量。这些创新有可能提供早期检测和治疗的机会,并通过补充和加强整个癌症连续性的提供者角色,扩大和简化癌症护理协调工作。可以利用技术缓解有限的资源,进而改善低收入癌症患者的长期癌症结果。虽然技术创新跨越了广泛的进步,但我们在此关注的是基于技术的干预,该干预服务于在整个癌症连续过程中增强患者能力的最终目标,作为可以通过基于技术的创新来支持癌症护理和管理的一个例子。
{"title":"Developing a technology-based intervention for empowering cancer patients from low-income backgrounds: a lifecycle approach","authors":"A. Varanasi, K. Helzlsouer","doi":"10.2147/IEH.S133549","DOIUrl":"https://doi.org/10.2147/IEH.S133549","url":null,"abstract":"Point your SmartPhone at the code above. If you have a QR code reader the video abstract will appear. Or use: https://youtu.be/Z2KpVhZQloE Abstract: Despite significant advances across the cancer continuum from prevention through survivorship, achieving uniform high-quality, patient-centered care for all remains a challenge. We have entered the era of precision medicine and multi-modal treatment where the promise of cure is great. Yet fragmented care and disparities in cancer outcomes persist, especially among those individuals from low income and underresourced backgrounds. Thoughtful, mindful, and purposeful implementation of technology-based innovations have the potential to empower cancer patients and improve longterm outcomes and overall quality of life. These innovations have the potential to provide access to early detection and treatment and to extend and streamline cancer care coordination efforts by complementing and enhancing provider roles throughout the cancer continuum. Technology can be leveraged to mitigate limited resources and in turn improve long-term cancer outcomes for low-income cancer patients. While innovations in technology span a broad spectrum of advancement, we focus here on a technologybased intervention that serves the end goal of empowering patients throughout the cancer continuum as an example of what can be done to support cancer care and management through technology-based innovations.","PeriodicalId":92213,"journal":{"name":"Innovation and entrepreneurship in health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IEH.S133549","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42079395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Elimination of preventable blindness: can success in Nepal be replicated in Africa? 消除可预防性失明:尼泊尔的成功能否在非洲复制?
Pub Date : 2018-07-01 DOI: 10.2147/IEH.S133527
Neda Nikpoor, Eric D. Hansen, M. Oliva, G. Tabin, S. Ruit
php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Innovation and Entrepreneurship in Health 2018:5 27–39 Innovation and Entrepreneurship in Health Dovepress
php,并包含知识共享署名-非商业(未启动,v3.0)许可证(http://creativecommons.org/licenses/by-nc/3.0/)。通过访问作品,您在此接受条款。作品的非商业用途是允许的,无需德芙医学出版社有限公司的任何进一步许可,前提是作品的归属正确。关于本作品的商业使用许可,请参阅我们的条款第4.2和第5段(https://www.dovepress.com/terms.php)。健康创新创业2018:527-39健康创新创业Dovepress
{"title":"Elimination of preventable blindness: can success in Nepal be replicated in Africa?","authors":"Neda Nikpoor, Eric D. Hansen, M. Oliva, G. Tabin, S. Ruit","doi":"10.2147/IEH.S133527","DOIUrl":"https://doi.org/10.2147/IEH.S133527","url":null,"abstract":"php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). Innovation and Entrepreneurship in Health 2018:5 27–39 Innovation and Entrepreneurship in Health Dovepress","PeriodicalId":92213,"journal":{"name":"Innovation and entrepreneurship in health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IEH.S133527","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44940066","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Socially assistive robots: current status and future prospects for autism interventions 社会辅助机器人:自闭症干预的现状和未来前景
Pub Date : 2018-06-01 DOI: 10.2147/IEH.S138753
Laurie A. Dickstein-Fischer, Darlene E. Crone-Todd, Ian Chapman, Ayesha T. Fathima, G. Fischer
: Social robots interact with people through social interactions, physical assistance, and therapy delivery. Socially assistive robots (SARs) are specifically intended to assist in a therapeutic way to help build social behavior skills. One area where SARs have gained significant attention is in the treatment and diagnosis of autism spectrum disorder. With the increase in rates of individuals diagnosed with autism spectrum disorder, there is an increasing need for equitable and accessible applied behavior analysis (ABA) therapy services. Current barriers for sufficient access to therapy include high administrative burden, burnout rates on the part of ABA therapists, and affordability of services. One way to reduce administrative burden is to automate procedures using computer-based interventions, including SARs. SARs have the potential to increase client engagement, while at the same time making it possible for therapists to provide a more interactive session for their client. We argue that there is benefit to clients, therapists, scientists, and to the general public if behavior analysts can work with robotic design engineers for further research and development on SARs. Such collaboration is necessary for ensuring that robust SAR designs are embedded in conceptually systematic approaches to ABA, while at the same time integrating relevant engineering design considerations. This technological integration is important for the field of ABA to move forward as robotics become more commonplace, and to effectively address the cost, quality, and access considerations involved.
:社交机器人通过社交互动、物理援助和治疗与人互动。社交辅助机器人(SAR)专门用于以治疗的方式帮助培养社交行为技能。严重急性呼吸系统综合征引起了极大关注的一个领域是自闭症谱系障碍的治疗和诊断。随着被诊断为自闭症谱系障碍的患者比例的增加,人们越来越需要公平和可获得的应用行为分析(ABA)治疗服务。目前,获得充分治疗的障碍包括高昂的行政负担、ABA治疗师的倦怠率以及服务的可负担性。减少行政负担的一种方法是使用计算机干预(包括严重急性呼吸系统综合征)实现程序自动化。严重急性呼吸系统综合征有可能增加客户参与度,同时使治疗师有可能为客户提供更具互动性的会话。我们认为,如果行为分析师能够与机器人设计工程师合作,进一步研究和开发严重急性呼吸系统综合征,对客户、治疗师、科学家和公众都有好处。这种合作对于确保稳健的SAR设计嵌入ABA的概念系统方法中是必要的,同时整合相关的工程设计考虑因素。随着机器人技术变得越来越普遍,这种技术集成对于ABA领域的发展非常重要,并有效地解决所涉及的成本、质量和访问问题。
{"title":"Socially assistive robots: current status and future prospects for autism interventions","authors":"Laurie A. Dickstein-Fischer, Darlene E. Crone-Todd, Ian Chapman, Ayesha T. Fathima, G. Fischer","doi":"10.2147/IEH.S138753","DOIUrl":"https://doi.org/10.2147/IEH.S138753","url":null,"abstract":": Social robots interact with people through social interactions, physical assistance, and therapy delivery. Socially assistive robots (SARs) are specifically intended to assist in a therapeutic way to help build social behavior skills. One area where SARs have gained significant attention is in the treatment and diagnosis of autism spectrum disorder. With the increase in rates of individuals diagnosed with autism spectrum disorder, there is an increasing need for equitable and accessible applied behavior analysis (ABA) therapy services. Current barriers for sufficient access to therapy include high administrative burden, burnout rates on the part of ABA therapists, and affordability of services. One way to reduce administrative burden is to automate procedures using computer-based interventions, including SARs. SARs have the potential to increase client engagement, while at the same time making it possible for therapists to provide a more interactive session for their client. We argue that there is benefit to clients, therapists, scientists, and to the general public if behavior analysts can work with robotic design engineers for further research and development on SARs. Such collaboration is necessary for ensuring that robust SAR designs are embedded in conceptually systematic approaches to ABA, while at the same time integrating relevant engineering design considerations. This technological integration is important for the field of ABA to move forward as robotics become more commonplace, and to effectively address the cost, quality, and access considerations involved.","PeriodicalId":92213,"journal":{"name":"Innovation and entrepreneurship in health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IEH.S138753","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47439929","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 27
Innovation Implementation in the Context of Hospital QI: Lessons Learned and Strategies for Success. 医院质量管理的创新实施:经验教训和成功策略。
Pub Date : 2018-01-01 Epub Date: 2018-02-21 DOI: 10.2147/IEH.S151040
Pavani Rangachari

In 1999, the Institute of Medicine reported that 98,000 people die each year due to medical errors. In the following years, the focus on hospital quality was intensified nationally, with policymakers providing evidence-based practice guidelines for improving health care quality. However, these innovations (evidence-based guidelines) that were being produced at policy levels were not translating to clinical practice at the hospital organizational level easily, and stark variations continued to persist, in the quality of health care. Circa 2009, nearly a decade after the release of the IOM report, the health care organizational literature began referring to this challenge as "innovation implementation failure" in health care organizations (HCOs), ie, failure to implement an evidence-based practice that is new to a HCO. This stream of literature drew upon management research to explain why innovation implementation failure occurs in HCOs and what could be done to prevent it. This paper conducts an integrative review of the literature on "innovation implementation" in hospitals and health systems over the last decade, since the spotlight was cast on "innovation implementation failure" in HCOs. The review reveals that while some studies have retrospectively sought to identify the key drivers of innovation implementation, through surveys and interviews of practitioners (the "what"), other studies have prospectively sought to understand how innovation implementation occurs in hospitals and health systems (the "how"). Both make distinctive contributions to identifying strategies for success in innovation implementation. While retrospective studies have helped identify the key drivers of innovation implementation, prospective studies have shed light on how these drivers could be attained, thereby helping to develop context-sensitive management strategies for success. The literature has called for more prospective research on the implementation and sustainability of health care innovations. This paper summarizes the lessons learned from the literature, discusses the relevance of management research on innovation implementation in HCOs, and identifies future research avenues.

1999年,医学研究所报告说,每年有98000人死于医疗事故。在接下来的几年里,全国加强了对医院质量的关注,政策制定者为提高医疗质量提供了基于证据的实践指南。然而,这些在政策层面产生的创新(基于证据的指导方针)并没有轻易转化为医院组织层面的临床实践,而且在卫生保健质量方面仍然存在明显的差异。大约在2009年,也就是IOM报告发布近十年后,卫生保健组织文献开始将这一挑战称为卫生保健组织(HCO)中的“创新实施失败”,即未能实施对卫生保健组织来说是新的循证实践。这一文献流借鉴了管理研究来解释为什么创新实施失败发生在hco和可以做些什么来防止它。本文对过去十年医院和卫生系统“创新实施”的文献进行了综合回顾,因为人们关注的焦点是hco的“创新实施失败”。回顾表明,虽然一些研究通过对从业者的调查和访谈(“什么”)回顾性地试图确定创新实施的关键驱动因素,但其他研究则前瞻性地试图了解医院和卫生系统如何实施创新(“如何”)。两者都对确定成功实施创新的战略做出了独特的贡献。虽然回顾性研究有助于确定创新实施的关键驱动因素,但前瞻性研究揭示了如何实现这些驱动因素,从而有助于制定成功的环境敏感管理策略。文献呼吁对卫生保健创新的实施和可持续性进行更多的前瞻性研究。本文总结了从文献中获得的经验教训,讨论了管理研究与hco创新实施的相关性,并确定了未来的研究途径。
{"title":"Innovation Implementation in the Context of Hospital QI: Lessons Learned and Strategies for Success.","authors":"Pavani Rangachari","doi":"10.2147/IEH.S151040","DOIUrl":"https://doi.org/10.2147/IEH.S151040","url":null,"abstract":"<p><p>In 1999, the Institute of Medicine reported that 98,000 people die each year due to medical errors. In the following years, the focus on hospital quality was intensified nationally, with policymakers providing evidence-based practice guidelines for improving health care quality. However, these innovations (evidence-based guidelines) that were being produced at policy levels were not translating to clinical practice at the hospital organizational level easily, and stark variations continued to persist, in the quality of health care. Circa 2009, nearly a decade after the release of the IOM report, the health care organizational literature began referring to this challenge as \"innovation implementation failure\" in health care organizations (HCOs), ie, failure to implement an evidence-based practice that is new to a HCO. This stream of literature drew upon management research to explain why innovation implementation failure occurs in HCOs and what could be done to prevent it. This paper conducts an integrative review of the literature on \"innovation implementation\" in hospitals and health systems over the last decade, since the spotlight was cast on \"innovation implementation failure\" in HCOs. The review reveals that while some studies have retrospectively sought to identify the key drivers of innovation implementation, through surveys and interviews of practitioners (the \"what\"), other studies have prospectively sought to understand how innovation implementation occurs in hospitals and health systems (the \"how\"). Both make distinctive contributions to identifying strategies for success in innovation implementation. While retrospective studies have helped identify the key drivers of innovation implementation, prospective studies have shed light on how these drivers could be attained, thereby helping to develop context-sensitive management strategies for success. The literature has called for more prospective research on the implementation and sustainability of health care innovations. This paper summarizes the lessons learned from the literature, discusses the relevance of management research on innovation implementation in HCOs, and identifies future research avenues.</p>","PeriodicalId":92213,"journal":{"name":"Innovation and entrepreneurship in health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IEH.S151040","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35920292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Smart implants in orthopedic surgery, improving patient outcomes: a review. 骨科手术中的智能植入物,改善患者预后:综述。
Pub Date : 2018-01-01 Epub Date: 2018-08-29 DOI: 10.2147/IEH.S133518
Eric H Ledet, Benjamin Liddle, Katerina Kradinova, Sara Harper

Smart implants are implantable devices that provide not only therapeutic benefits but also have diagnostic capabilities. The integration of smart implants into daily clinical practice has the potential for massive cost savings to the health care system. Applications for smart orthopedic implants have been identified for knee arthroplasty, hip arthroplasty, spine fusion, fracture fixation and others. To date, smart orthopedic implants have been used to measure physical parameters from inside the body, including pressure, force, strain, displacement, proximity and temperature. The measurement of physical stimuli is achieved through integration of application-specific technology with the implant. Data from smart implants have led to refinements in implant design, surgical technique and strategies for postoperative care and rehabilitation. In spite of decades of research, with very few exceptions, smart implants have not yet become a part of daily clinical practice. This is largely because integration of current sensor technology necessitates significant modification to the implants. While the technology underlying smart implants has matured significantly over the last several decades, there are still significant technical challenges that need to be overcome before smart implants become part of mainstream health care. Sensors for next-generation smart implants will be small, simple, robust and inexpensive and will necessitate little to no modification to existing implant designs. With rapidly advancing technology, the widespread implementation of smart implants is near. New sensor technology that minimizes modifications to existing implants is the key to enabling smart implants into daily clinical practice.

智能植入物是一种植入式设备,不仅提供治疗效果,还具有诊断能力。将智能植入物整合到日常临床实践中,有可能为医疗保健系统节省大量成本。智能骨科植入物的应用已被确定为膝关节置换术、髋关节置换术、脊柱融合、骨折固定等。迄今为止,智能骨科植入物已被用于测量身体内部的物理参数,包括压力、力、应变、位移、接近度和温度。物理刺激的测量是通过与植入物集成特定应用技术来实现的。来自智能植入物的数据导致了植入物设计、手术技术和术后护理和康复策略的改进。尽管经过数十年的研究,除了极少数例外,智能植入物尚未成为日常临床实践的一部分。这主要是因为当前传感器技术的集成需要对植入物进行重大修改。虽然在过去的几十年里,智能植入物的基础技术已经显著成熟,但在智能植入物成为主流医疗保健的一部分之前,仍有重大的技术挑战需要克服。下一代智能植入物的传感器将是小、简单、坚固和廉价的,并且几乎不需要对现有植入物设计进行修改。随着技术的快速发展,智能植入物的广泛应用即将到来。新的传感器技术可以最大限度地减少对现有植入物的修改,这是使智能植入物进入日常临床实践的关键。
{"title":"Smart implants in orthopedic surgery, improving patient outcomes: a review.","authors":"Eric H Ledet,&nbsp;Benjamin Liddle,&nbsp;Katerina Kradinova,&nbsp;Sara Harper","doi":"10.2147/IEH.S133518","DOIUrl":"https://doi.org/10.2147/IEH.S133518","url":null,"abstract":"<p><p>Smart implants are implantable devices that provide not only therapeutic benefits but also have diagnostic capabilities. The integration of smart implants into daily clinical practice has the potential for massive cost savings to the health care system. Applications for smart orthopedic implants have been identified for knee arthroplasty, hip arthroplasty, spine fusion, fracture fixation and others. To date, smart orthopedic implants have been used to measure physical parameters from inside the body, including pressure, force, strain, displacement, proximity and temperature. The measurement of physical stimuli is achieved through integration of application-specific technology with the implant. Data from smart implants have led to refinements in implant design, surgical technique and strategies for postoperative care and rehabilitation. In spite of decades of research, with very few exceptions, smart implants have not yet become a part of daily clinical practice. This is largely because integration of current sensor technology necessitates significant modification to the implants. While the technology underlying smart implants has matured significantly over the last several decades, there are still significant technical challenges that need to be overcome before smart implants become part of mainstream health care. Sensors for next-generation smart implants will be small, simple, robust and inexpensive and will necessitate little to no modification to existing implant designs. With rapidly advancing technology, the widespread implementation of smart implants is near. New sensor technology that minimizes modifications to existing implants is the key to enabling smart implants into daily clinical practice.</p>","PeriodicalId":92213,"journal":{"name":"Innovation and entrepreneurship in health","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/IEH.S133518","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36516187","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 71
期刊
Innovation and entrepreneurship in health
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1